A detailed history of First Trust Advisors LP transactions in Eli Lilly & CO stock. As of the latest transaction made, First Trust Advisors LP holds 88,722 shares of LLY stock, worth $70.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
88,722
Previous 87,373 1.54%
Holding current value
$70.6 Million
Previous $79.1 Million 0.64%
% of portfolio
0.08%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $1.04 Million - $1.3 Million
1,349 Added 1.54%
88,722 $78.6 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $4.1 Million - $5.14 Million
5,657 Added 6.92%
87,373 $79.1 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $3.06 Million - $4.09 Million
-5,159 Reduced 5.94%
81,716 $63.6 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $192 Million - $227 Million
-366,393 Reduced 80.83%
86,875 $50.6 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $10.5 Million - $14.4 Million
-24,058 Reduced 5.04%
453,268 $243 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $39.4 Million - $52.7 Million
-112,331 Reduced 19.05%
477,326 $224 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $21.7 Million - $25.5 Million
-69,962 Reduced 10.61%
589,657 $203 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $22.3 Million - $26 Million
-69,389 Reduced 9.52%
659,619 $241 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $151 Million - $172 Million
507,733 Added 229.46%
729,008 $236 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $40.5 Million - $47.6 Million
-145,386 Reduced 39.65%
221,275 $71.7 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $236,098 - $293,409
-1,006 Reduced 0.27%
366,661 $105 Million
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $11.9 Million - $14.8 Million
-53,007 Reduced 12.6%
367,667 $102 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $7.07 Million - $8.7 Million
31,890 Added 8.2%
420,674 $97.2 Million
Q2 2021

Oct 12, 2021

SELL
$180.55 - $233.54 $422,487 - $546,483
-2,340 Reduced 0.6%
388,784 $89.1 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $1.8 Million - $2.33 Million
9,972 Added 2.62%
391,124 $89.8 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $216 Million - $279 Million
-1,313,161 Reduced 77.5%
381,152 $71.2 Million
Q4 2020

Feb 02, 2021

BUY
$130.46 - $172.63 $16.8 Million - $22.2 Million
128,613 Added 8.21%
1,694,313 $286 Million
Q3 2020

Nov 05, 2020

BUY
$146.22 - $169.13 $67.1 Million - $77.6 Million
458,790 Added 41.45%
1,565,700 $232 Million
Q2 2020

Jul 22, 2020

BUY
$136.42 - $164.18 $31 Million - $37.3 Million
227,392 Added 25.85%
1,106,910 $182 Million
Q1 2020

May 06, 2020

SELL
$119.05 - $147.35 $16.4 Million - $20.4 Million
-138,151 Reduced 13.58%
879,518 $122 Million
Q4 2019

Feb 03, 2020

BUY
$106.92 - $132.43 $8.85 Million - $11 Million
82,786 Added 8.86%
1,017,669 $134 Million
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $4.32 Million - $4.7 Million
-40,467 Reduced 4.15%
934,883 $105 Million
Q2 2019

Jul 30, 2019

BUY
$110.79 - $129.32 $25.1 Million - $29.3 Million
226,281 Added 30.21%
975,350 $108 Million
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $19.3 Million - $22.7 Million
-173,344 Reduced 18.79%
749,069 $97.2 Million
Q4 2018

Feb 07, 2019

BUY
$105.9 - $118.64 $57.4 Million - $64.3 Million
542,013 Added 142.49%
922,413 $107 Million
Q3 2018

Oct 25, 2018

BUY
$85.86 - $107.31 $8.47 Million - $10.6 Million
98,646 Added 35.01%
380,400 $40.8 Million
Q2 2018

Aug 02, 2018

SELL
$75.7 - $86.88 $19.4 Million - $22.2 Million
-256,036 Reduced 47.61%
281,754 $24 Million
Q1 2018

Apr 23, 2018

BUY
$74.21 - $87.6 $4.49 Million - $5.3 Million
60,500 Added 12.68%
537,790 $41.6 Million
Q4 2017

Feb 08, 2018

BUY
$81.94 - $87.89 $7.83 Million - $8.4 Million
95,584 Added 25.04%
477,290 $40.3 Million
Q3 2017

Oct 24, 2017

BUY
$77.07 - $85.54 $29.4 Million - $32.7 Million
381,706
381,706 $32.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.